A detailed history of First Trust Advisors LP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 756,809 shares of IBRX stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
756,809
Previous 887,620 14.74%
Holding current value
$1.99 Million
Previous $5.61 Million 49.96%
% of portfolio
0.0%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.32 - $6.7 $434,292 - $876,433
-130,811 Reduced 14.74%
756,809 $2.81 Million
Q2 2024

Aug 13, 2024

BUY
$4.82 - $9.15 $4.28 Million - $8.12 Million
887,620 New
887,620 $5.61 Million
Q1 2023

May 15, 2023

BUY
$1.35 - $4.78 $131,071 - $464,090
97,090 Added 166.23%
155,497 $283,000
Q4 2022

Feb 09, 2023

SELL
$4.35 - $6.77 $73,784 - $114,832
-16,962 Reduced 22.51%
58,407 $296,000
Q3 2022

Nov 14, 2022

BUY
$3.65 - $6.43 $54,374 - $95,787
14,897 Added 24.63%
75,369 $375,000
Q2 2022

Aug 12, 2022

BUY
$2.68 - $6.14 $162,064 - $371,298
60,472 New
60,472 $225,000
Q3 2021

Nov 15, 2021

SELL
$9.17 - $14.24 $2.29 Million - $3.56 Million
-250,096 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$13.41 - $22.4 $815,649 - $1.36 Million
-60,824 Reduced 19.56%
250,096 $3.57 Million
Q1 2021

May 14, 2021

BUY
$12.83 - $42.25 $3.99 Million - $13.1 Million
310,920 New
310,920 $7.38 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.